IDEXX Laboratories (IDXX) Revenue — Quarter Ended Jun 30, 2025
Revenue for the quarter rose compared to the prior quarter and also increased relative to the same period a year ago. The sequential growth was notably stronger than the gains seen in previous quarters.
Key takeaway
Quarter ended Jun 30, 2025 · FY2025 Q2
Revenue for the quarter rose compared to the prior quarter and also increased relative to the same period a year ago. The sequential growth was notably stronger than the gains seen in previous quarters.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.1B
Revenue reported for this quarter.
Quarter-over-quarter
+11.1%
Change from the immediately preceding quarter.
Year-over-year
+10.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2024 | $975.5M | +6.6% |
| Dec 31, 2024 | $954.3M | +5.8% |
| Mar 31, 2025 | $998.4M | +3.6% |
| Jun 30, 2025 | $1.1B | +10.6% |
Revenue performance
The reported revenue moved higher, reflecting an improvement from the preceding quarter.
Quarterly comparison
Compared to the immediately preceding quarter, revenue was higher. Compared to the same quarter one year earlier, revenue also showed an increase.
What to watch
The filing notes a reduction in working capital driven by lower cash and higher credit facility borrowings, which may warrant attention.